Last Posted: Jan 10, 2020
- Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer
WA Woordward et al, JAMA Oncology, January 9, 2020 - Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia.
Bilgin Emre et al. Rheumatology international 2019 Jun 39(6) 1045-1051 - Cancer registries - guardians of breast cancer biomarker information: A systematic review.
Voith von Voithenberg Lena et al. The International journal of biological markers 2019 Jun 34(2) 194-199 - Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
Gwark Sung-Chan et al. Annals of surgical oncology 2019 Jul 26(7) 2166-2174 - The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
Murakami Wakana et al. Breast cancer (Tokyo, Japan) 2019 Sep 26(5) 552-561 - TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.
Albert Catherine M et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 37(6) 513-524 - Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer.
Yoon Kyung-Hwak et al. Journal of breast cancer 2019 Dec 22(4) 587-598 - Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
Gao Ya et al. Clinical and experimental medicine 2020 Jan - Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
Tynan Mara et al. Breast cancer research and treatment 2020 Jan - Prognostic Role of KRAS mRNA Expression in Breast Cancer.
Hwang Ki-Tae et al. Journal of breast cancer 2019 Dec 22(4) 548-561
.png)
No hay comentarios:
Publicar un comentario